Search research articles
Contact Us
Filters
Showing results (211-220 of 269) with videos related to
Page
of 27
Sort By:
Therapeutic Drug Monitoring
|
November 1, 1989
Time-dependent pharmacodynamic effects of phenobarbital in humans
N Barzaghi, G Gatti, R Manni, et al.
Epilepsia
|
June 15, 1999
Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women
C Fattore, G Cipolla, G Gatti, et al.
British Journal of Clinical Pharmacology
|
June 1, 1984
Differential transplacental binding of valproic acid: influence of free fatty acids
F Albani, R Riva, M Contin, et al.
British Journal of Clinical Pharmacology
|
July 1, 1984
Pharmacokinetic and pharmacodynamic studies with a new controlled-release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations
E Perucca, R Grimaldi, G Gatti, et al.
Pharmacopsychiatry
|
March 1, 1987
Pharmacokinetic-dynamic study on different oral biperiden formulations in volunteers
M Hollmann, H Müller-Peltzer, G Greger, et al.
British Journal of Clinical Pharmacology
|
June 1, 1996
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients
M Giaccone, A Bartoli, G Gatti, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
January 1, 1991
Comparative pharmacokinetics and pharmacodynamics of eterobarbital and phenobarbital in normal volunteers
N Barzaghi, G Gatti, R Manni, et al.
Epilepsy Research
|
August 30, 2000
Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician
D Schmidt, L Gram, M Brodie, et al.
Therapeutic Drug Monitoring
|
June 12, 1999
Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders
G Facciolà, A Avenoso, M G Scordo, et al.
Neurology
|
March 1, 1996
Choreiform syndrome associated with fluoxetine treatment in a patient with deficient CYP2D6 activity
E Marchioni, E Perucca, D Soragna, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 269) with videos related to
Sort By:
Page
of 27
Therapeutic Drug Monitoring
|
November 1, 1989
Time-dependent pharmacodynamic effects of phenobarbital in humans
N Barzaghi, G Gatti, R Manni, et al.
Epilepsia
|
June 15, 1999
Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women
C Fattore, G Cipolla, G Gatti, et al.
British Journal of Clinical Pharmacology
|
June 1, 1984
Differential transplacental binding of valproic acid: influence of free fatty acids
F Albani, R Riva, M Contin, et al.
British Journal of Clinical Pharmacology
|
July 1, 1984
Pharmacokinetic and pharmacodynamic studies with a new controlled-release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations
E Perucca, R Grimaldi, G Gatti, et al.
Pharmacopsychiatry
|
March 1, 1987
Pharmacokinetic-dynamic study on different oral biperiden formulations in volunteers
M Hollmann, H Müller-Peltzer, G Greger, et al.
British Journal of Clinical Pharmacology
|
June 1, 1996
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients
M Giaccone, A Bartoli, G Gatti, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
January 1, 1991
Comparative pharmacokinetics and pharmacodynamics of eterobarbital and phenobarbital in normal volunteers
N Barzaghi, G Gatti, R Manni, et al.
Epilepsy Research
|
August 30, 2000
Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician
D Schmidt, L Gram, M Brodie, et al.
Therapeutic Drug Monitoring
|
June 12, 1999
Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders
G Facciolà, A Avenoso, M G Scordo, et al.
Neurology
|
March 1, 1996
Choreiform syndrome associated with fluoxetine treatment in a patient with deficient CYP2D6 activity
E Marchioni, E Perucca, D Soragna, et al.
Page
of 27